TY - STD TI - Máca J, Jor O, Holub M, Sklienka P, Burša F, Burda M, et al. Past and present ARDS mortality rates: a systematic review. Respir Care 2017; 62:113–122. http://doi: https://doi.org/10.4187/respcare.04716. ID - ref1 ER - TY - STD TI - Li SL, Wang X, Li SJ, Yan J. High-frequency oscillatory ventilation for cardiac surgery children with severe acute respiratory distress syndrome. Pediatr Cardiol 2013;34:1382–1388. http://doi: https://doi.org/10.1007/s00246-013-0655-y. ID - ref2 ER - TY - STD TI - Bandiya P, Nangia S, Saili A. Surfactant lung lavage vs. standard Care in the Treatment of meconium aspiration syndrome-a randomized trial. J Trop Pediatr 2019;65:114–121. http://doi: https://doi.org/10.1093/tropej/fmy024. ID - ref3 ER - TY - STD TI - Deshpande S, Suryawanshi P, Ahya K, Maheshwari R, Gupta S. Surfactant therapy for early onset pneumonia in late preterm and term neonates needing mechanical ventilation. J Clin Diagn Res 2017;11:9–12. http://doi: https://doi.org/10.7860/JCDR/2017/28523.10520. ID - ref4 ER - TY - STD TI - Keszler M, Sant'Anna G. Mechanical ventilation and Bronchopulmonary dysplasia. Clin Perinatol 2015;42:781–796. http://doi: https://doi.org/10.1016/j.clp.2015.08.006. ID - ref5 ER - TY - STD TI - Bautin A, Khubulava G, Kozlov I. Surfactant therapy for patients with ARDS after cardiac surgery. J Liposome Res 2006;16:265–272. http://doi: https://doi.org/10.1080/08982100600850997. ID - ref6 ER - TY - STD TI - Amigoni A, Pettenazzo A, Stritoni V, Circelli M. Surfactants in acute respiratory distress syndrome in infants and children: past, present and future. Clin Drug Investig 2017;37:729–736. http://doi: https://doi.org/10.1007/s40261-017-0532-1. ID - ref7 ER - TY - STD TI - Willson DF, Chess PR, Notter RH. Surfactant for pediatric acute lung injury. Pediatr Clin N Am 2008;55:545–575. http://doi: https://doi.org/10.1016/j.pcl.2008.02.016. ID - ref8 ER - TY - STD TI - Playfor SD, Nootigattu VK. Exogenous surfactant in paediatric acute lung injury and acute respiratory distress syndrome. Curr Drug Saf 2006;1:159–168. http://doi: https://doi.org/10.2174/157488606776930553. ID - ref9 ER - TY - STD TI - Haslam PL, Baker CS, Hughes DA, MacNaughton PD, Moat NE, Dewar A, et al. Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass: prophylactic use of surfactant therapy. Int J Exp Pathol 1997;78:277–289. http://doi: https://doi.org/10.1046/j.1365-2613.1997.330364.x. ID - ref10 ER - TY - STD TI - Ozguler IM, Burma O, Uysal A, Akbulut H. Rosuvastatin lowers systemic inflammatory response in coronary artery bypass graft accompanied by cardiopulmonary bypass surgery: a randomized controlled study. Clin Invest Med. 2015;38:154–163. http://doi: https://doi.org/10.25011/cim.v38i4.24260. ID - ref11 ER - TY - STD TI - Wagner R, Piler P, Uchytil B, Halouzka R, Kovaru H, Bobkova M, et al. Systemic inflammatory response syndrome is reduced by preoperative plasma-thrombo-leukocyte aphaeresis in a pig model of cardiopulmonary bypass. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016;160:399–406. http://doi: https://doi.org/10.5507/bp.2016.010. ID - ref12 ER - TY - STD TI - Cai J, Su Z, Zhou Y, Shi Z, Shi Z, Xu Z, Liu J, et al. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery. Eur J Cardiothorac Surg 2011;40:557–562. http://doi: https://doi.org/10.1016/j.ejcts.2011.01.008. ID - ref13 ER - TY - STD TI - Halliday HL, Tarnow-Mordi WO, Corcoran JD, Patterson CC. Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child 1993;69:276–280. http://doi: https://doi.org/10.1136/adc.69.3_spec_no.276. ID - ref14 ER - TY - STD TI - Möller JC, Schaible T, Roll C, Schiffmann JH, Bindl L, Schrod L, et al. Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med 2003;29:437–446. http://doi: https://doi.org/10.1007/s00134-003-1650-1. ID - ref15 ER - TY - STD TI - Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818–824. http://doi: https://doi.org/10.1164/ajrccm.149.3.7509706. ID - ref16 ER - TY - STD TI - Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–710. http://doi: https://doi.org/10.1007/BF01709751. ID - ref17 ER - TY - STD TI - Fujii Y, Shirai M, Pearson JT, Dziuba F, Horke A, Kaussen T, et al. Changes in inflammatory response during and after cardiopulmonary bypass using a rat extracorporeal circulation model. Conf Proc IEEE Eng Med Biol Soc 2015;2015:957–960. http://doi: https://doi.org/10.1109/EMBC. ID - ref18 ER - TY - STD TI - Hamlington KL, Bates JHT, Roy GS, Charlebois C, Suki B, Smith BJ. Alveolar leak develops by a rich-get-richer process in ventilator-induced lung injury. PLoS One 2018;13:e0193934. http://doi: https://doi.org/10.1371/journal.pone.0193934. ID - ref19 ER - TY - STD TI - Dushianthan A, Cusack R, Goss V, Postle AD, Grocott MP. Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome-where do we go from here? Crit Care 2012;16:238–249. http://doi: https://doi.org/10.1186/cc11512. ID - ref20 ER - TY - STD TI - Rodríguez-Moya VS, Gallo-Borrero CM, Santos-Áreas D, Prince-Martínez IA, Díaz-Casañas E, López-Herce Cid J. Exogenous surfactant and alveolar recruitment in the treatment of the acute respiratory distress syndrome. Clin Respir J 2017;11:1032–1039. http://doi: https://doi.org/10.1111/crj.12462. ID - ref21 ER - TY - STD TI - Boehne M, Sasse M, Karch A, Friederike Dziuba, Alexander Horke, Torsten Kaussen, et al. Systemic inflammatory response syndrome after pediatric congenital heart surgery: incidence, risk factors, and clinical outcome. J Card Surg 2017;32:116–125. http://doi: https://doi.org/10.1111/jocs.12879. ID - ref22 ER - TY - JOUR AU - Matuschak, G. M. AU - Lechner, A. J. PY - 2010 DA - 2010// TI - Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment JO - Mo Med VL - 107 ID - Matuschak2010 ER - TY - STD TI - Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005;293:470–476. http://doi: https://doi.org/10.1001/jama.293.4.470. ID - ref24 ER - TY - STD TI - Alten JA, Borasino S, Pearce FB, Dabal RJ, Kirklin JK. Surfactant treatment for congenital heart disease patients with acute respiratory distress syndrome. Congenit Heart Dis 2010;5:624–628. http://doi: https://doi.org/10.1111/j.1747-0803.2010.00412.x. ID - ref25 ER - TY - STD TI - Qiu W, Zheng L, Gu H, Chen D, Chen Y. Comparison between adult and infant lung injury in a rabbit ischemia-reperfusion model. J Thorac Cardiovasc Surg 2008;136:352–359. http://doi: https://doi.org/10.1016/j.jtcvs.2008.01.014. ID - ref26 ER - TY - STD TI - Filoche M, Tai CF, Grotberg JB. Three-dimensional model of surfactant replacement therapy. Proc Natl Acad Sci U S A 2015;112:9287–9292. http://doi: https://doi.org/10.1073/pnas.1504025112. ID - ref27 ER -